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Hypersensitivity to mosquito bites (HMB) is a cutaneous disorder belonging to
the group of Epstein–Barr virus (EBV)-associated T ⁄natural killer (NK)-cell lympho-
proliferative diseases, and is primarily mediated by EBV-infected NK cells. It is
characterized by intense local skin reactions accompanied by general symptoms
after mosquito bites, and infiltration of EBV-infected NK cells into the bite sites.
However, the mechanisms underlying these reactions have not been fully exam-
ined. We recently described the activation of circulating basophils by mosquito
extracts in vitro in a patient with HMB. To further investigate this finding, we
studied four additional patients with HMB. All patients showed typical clinical
features of HMB after mosquito bites and they had NK lymphocytosis and high
peripheral blood EBV DNA loads. We found evidence of EBV infection in NK cells
through in situ hybridization that detected EBV-encoded small RNA-1, and flow
cytometry showed HLA-DR expression on almost all NK cells. Basophil activation
tests with the extracts of epidemic mosquitoes Culex pipiens pallens and Aedes
albopictus showed positive responses to one or both extracts in all samples from
patients with HMB, suggesting the presence of mosquito antigen-specific IgE and
its binding to basophils. In particular, the extract of Aedes albopictus was able to
activate basophils in all available patient samples. These results indicate that ba-
sophils and ⁄or mast cells activated by mosquito bites may be involved in initia-
tion and development of severe skin reactions to mosquito bites in HMB.
M ore than 90% of humans are infected with the Epstein–Barr virus (EBV) and the infection persists for life.(1)
EBV mostly infects B cells in healthy persons who are often
asymptomatic or may occasionally develop infectious mononu-
cleosis (IM).(2) It rarely infects T or natural killer (NK) cells
in healthy children and young adults, and the chronic prolifera-
tion of those EBV-infected cells causes EBV-associated T
⁄NK-cell lymphoproliferative diseases.(3) EBV-associated T
⁄NK-cell lymphoproliferative diseases present with diverse
clinical and pathological findings, and were classified into the
following disorders at the 2012 lymphoma workshop of the
European Association for Haematopathology meeting: (i)
chronic active EBV infection (CAEBV); (ii) systemic, malig-
nant EBV-positive lymphoproliferative diseases; (iii) extranod-
al NK-cell ⁄T-cell lymphoma, nasal type; and (iv) nodal T-cell
⁄NK-cell lymphoma.(4) CAEBV include the systemic type,
hydroa vacciniforme and hypersensitivity to mosquito bites
(HMB).
Hypersensitivity to mosquito bites is a cutaneous disorder
characterized by intense local skin reactions manifesting as
erythema, bullae, ulcers and scar formation accompanied by
systemic symptoms, including high fever, lymphadenopathy,
liver dysfunction and the hemophagocytic syndrome after mos-
quito bites.(5) HMB has also been regarded as severe mosquito
allergy, but such severe skin lesions and clonal proliferation of
EBV-infected cells do not occur in simple allergy. The major
cellular targets of latent EBV infection in HMB are NK cells,
and NK cell lymphocytosis and high IgE levels are characteris-
tic laboratory findings.(6) The pathogenesis of HMB has not
been well defined. The mosquito bite site in patients with
HMB showed perivascular mononuclear cell infiltration with
an increased number of EBV-infected NK cells and CD4+ T
cells.(7) In addition, it has been reported that CD4+ T cells
from patients responded markedly to mosquito salivary gland
extracts in vitro and that these CD4+ T cells stimulated by the
mosquito antigen were able to induce reactivation of latent
EBV infection and the proliferation of NK cells in vitro.(5,8)
Thus, CD4+ T cells and EBV-infected NK cells are considered
to be involved in the pathogenesis of HMB. Nevertheless, our
previous study demonstrated that there were not only T and
NK cells but also many CD203c+ cells, representing basophils
and ⁄ or mast cells, in the blister fluids from a patient with
HMB.(9) In addition, we found basophil activation with expo-
sure to the extract of Aedes albopictus (Ae. albopictus) in the
basophil activation test (BAT). These findings suggest the pos-
sible involvement of mosquito-specific IgE and CD203c+ cells
in the severe skin reactions to mosquito bites in HMB.
Basophils and mast cells are similar in terms of expression
of the high-affinity IgE receptor and the secretion of cytokines
and inflammatory mediators upon stimulation.(10) Therefore, in
human studies, basophils have often been utilized as surrogates
of tissue-resident mast cells in vitro because basophils are eas-
ily accessible in the peripheral blood, in contrast to mast
cells.(11,12) BAT is a flow cytometry-based test that measures
basophil activation markers like CD63 and CD203c on the sur-
face of basophils after in vitro stimulation with allergens.
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Because BAT has high sensitivity and specificity, it has been
recently applied as an in vitro diagnostic method for various
IgE-mediated allergic diseases.(13)
There are no studies apart from our previous study that
examine basophils in patients with HMB. The present study
aims to clarify the existence of mosquito antigen-specific IgE
in HMB by using BAT and shows that in addition to mosquito
antigen-specific CD4+ T cells and EBV-infected NK cells, ba-
sophils and ⁄or mast cells activated by mosquito bites may be
involved in the pathogenesis of HMB.
Materials and Methods
Patients. We evaluated five Japanese patients with HMB. All
patients were previously healthy, and their family histories
were unremarkable. Table 1 presents the clinical and labora-
tory data of the patients. The data for P1 have been reported
elsewhere.(9) All but P5 were diagnosed and analyzed within
1 year after onset. P5 was referred to our hospital when he
was 19 years old because of a change in his address, and he
was analyzed at that time. All patients showed typical clinical
features of HMB, such as intense local skin reactions accom-
panied by general symptoms including fever and abnormal
liver function after mosquito bites. Serological tests for EBV
showed modestly elevated titers of antiviral capsid antigen
immunoglobulin G, positive anti-EBV nuclear antigen titers
and the absence of antiviral capsid antigen immunoglobulin M,
which indicated past infection in the studied patients. EBV
DNA loads in the peripheral blood were markedly increased in
all patients. None of the patients had an increase in basophil
counts. Consistent with a previous report,(6) all patients had
elevated levels of serum IgE. Thus, all five patients were diag-
nosed with HMB according to the diagnostic guidelines.(14)
Serum mosquito-specific IgE measured by commercial fluoren-
zymeimmunoassay was negative in P1 and P3 (<0.34 UA
⁄mL), and weakly positive in P2 (0.80 UA ⁄mL). The remain-
ing patients were not tested because no appropriate sample
was available. Approval for the study was obtained from the
Human Research Committee of Kanazawa University Graduate
School of Medical Science, and written informed consent was
obtained in accordance with the Declaration of Helsinki.
Cell preparation and in situ hybridization for Epstein–Barr
virus-encoded small RNA-1. Peripheral blood mononuclear cells
(PBMC) were isolated by Ficoll–Hypaque gradient centrifuga-
tion. Peripheral blood lymphocytes were prepared from PBMC
by depletion of monocytes using anti-CD14 monoclonal anti-
body (mAb)-coated magnetic beads (Becton Dickinson San
Diego, CA, USA). CD4+ T, CD8+ T, CD19+ B and CD56+
NK cells were then purified by positive selection from periph-
eral blood lymphocytes using the respective mAb-coated mag-
netic beads (Becton Dickinson). With P5, CD16+ NK cells
were purified by positive selection using phycoerythrin (PE)-
conjugated anti-CD16 mAb and anti-PE-conjugated magnetic
beads (Becton Dickinson). B cells were prepared by removal
of CD4+, CD8+ and CD16+ cells. The purity of cells from P1
has been reported elsewhere.(9) The purity of the isolated
CD4+ T, CD8+ T, CD19+ B and CD56+ NK cells from P2 was
95.8%, 93.6%, 99.6% and 96.3%, respectively, as determined
by flow cytometric analysis. Separation of lymphocyte subsets
from P3 could not be done because of limited sample avail-
ability. The purity of the isolated CD4+ T, CD8+ T, CD19+ B
and CD56+ NK cells from P4 was 98.4%, 97.9%, 80.7% and
93.2%, respectively. The purity of the isolated CD4+ T, CD8+
T, CD20+ B and CD16+ NK cells from P5 was 98.9%, 86.0%,
58.5% and 76.9%, respectively. Because of the negative selec-
tion, isolated B cells exhibited low purity and comprised
28.6% of the contaminating CD56+ NK cells from P5. In situ
hybridization for EBV-encoded small RNA-1 (EBER-1) was
performed as described previously.(15)
Flow cytometric analysis. For the analysis, whole blood sam-
ples were used within 24 h after collection. None of the
patients were receiving any treatment at the time of sample
Table 1. Patient characteristics
P1 P2 P3 P4 P5
Normal
range
Age at onset (years) 7 7 8 9 1
Age at diagnosis 7 8 9 11 4
Sex M M M F M














EBV VCA IgG (fold) 80 80 40 640 NA <10
EBV VCA IgM (fold) <10 <10 NA <10 NA <10
EBNA (fold) 40 20 80 10 NA <10
EBV DNA loads
(copies ⁄ 106 WBC)
1 300 000 66 000 28 000 21 000 37 300† <20
Lymphocyte subsets (%)
CD3+ T cells 26.2 47.5 15.2 42.7 44.8 69.5  4.6
CD4+ T cells 17.4 25.9 8.5 29.4 34.8 43.1  6.0
CD8+ T cells 7.4 19.2 6.6 11.4 9.8 22.0  5.4
CD20+ B cells 5.6 17.9 14.1 7.1 12.4 11.2  3.5
CD56+ NK cells 55.6 33.8 59.7 33.5 28.7 12.8  5.3
CD203c+ basophils 0.28 0.68 0.16 1.10 NA 0.53  0.28
Total IgE (IU ⁄ mL) 1338 3480 10 020 3177 8910 <696
†It was expressed as copies ⁄ lg DNA in peripheral blood mononuclear cells. EBNA, Epstein–Barr virus nuclear antigen; EBV, Epstein–Barr virus;
NA, not applicable; VCA, viral capsid antigen; WBC, white blood cells.
© 2015 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd
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collection. The distribution of lymphocyte subsets was ana-
lyzed using FACSCalibur flow cytometer using CellQuest soft-
ware (BD Bioscience, Tokyo, Japan). HLA-DR was the
activation marker that was evaluated on CD3+ T cells and
CD16+ or CD56+ NK cells. A total of 12 healthy subjects and
4 volunteers with simple mosquito allergies were also studied
as controls. Simple mosquito allergy was defined as large local
reactions but not systemic reactions after mosquito bites.(16)
Those with simple mosquito allergies were excluded from the
group of healthy controls. The following mAb were used:
FITC-conjugated anti-HLA-DR, and PE-conjugated anti-CD3
or anti-CD56 (Becton Dickinson PharMingen, San Diego, CA,
USA); PE-conjugated anti-CD4, anti-CD8 or anti-CD20
(DAKO, Glostrup, Denmark); and PE-conjugated anti-CD16
(Immunotech, Marseille, France). Analysis of differences
among the data groups was performed using Student’s t-test
for unpaired samples. P-values < 0.05 were considered to indi-
cate statistical significance.
Mosquito extracts and basophil activation test. We prepared
mosquito extracts and performed BAT using blood samples
from five patients with HMB, 12 healthy controls and five vol-
unteers with simple mosquito allergy as described previ-
ously.(9) Two mosquito species, Culex pipiens pallens
(C. p. pallens) and Ae. Albopictus, which are endemic in
Japan, were used (Sumika Technoservice, Takarazuka, Hyogo,
Japan). Mosquito extracts were composed of whole bodies. A
total of 100 mosquitoes were homogenized in 2 mL of phos-
phate-buffered saline, and the samples were centrifuged at
3000 g for 10 min. The supernatants were then centrifuged
at 14 000 g for 10 min. The mosquito extracts were stored at
80°C until use. The total protein concentrations of the
extracts of C. p. pallens and Ae. albopictus were 7.0 and
6.6 mg ⁄mL, respectively, as assessed by BCA protein assay
(Pierce, Rockford, IL, USA).(17) For BAT,(18) peripheral whole
blood was obtained, washed twice in PBS and suspended in
RPMI1640 medium (Gibco, Grand Island, NY, USA) contain-
ing 10% FBS and antibiotics. Aliquots (200 lL) were incu-
bated with or without 101 or 102 dilutions of the mosquito
extracts at 37°C for 40 min. Cells were then washed and incu-
bated with FITC-conjugated anti-CD63 and PE-conjugated
anti-CD203c mAbs (Immunotech) on ice in the dark for
20 min. Stained cells were analyzed in a FACSCalibur flow
cytometer and basophils were detected on the basis of forward
side scatter characteristics and expression of CD203c. Results
of activated basophils were given as the percentage of basoph-
ils expressing CD63 among the total number of identified ba-
sophils and CD203c expression was evaluated by the mean
fluorescence intensity. Analysis of differences among the data
groups was performed using Student’s t-test for unpaired sam-
ples. P-values < 0.05 were considered to indicate statistical
significance.
Results
Cellular target of Epstein–Barr virus in hypersensitivity to mos-
quito bites. To determine which populations of lymphocytes
were infected with EBV, we performed in situ hybridization to
identify EBER-1 in each lymphocyte subpopulation that had
been isolated from patients with HMB. Figure 1(a) shows repre-
sentative pictures of in situ hybridization for EBER-1 where P1
had a number of EBER-1-positive cells among CD56+ NK cells,
in contrast to EBER-1 positivity in CD4+, CD8+ T and CD19+ B
cells. Figure 1(b) shows the percentages of EBER-1-positive
cells in the population of PBMC and isolated lymphocyte sub-
populations. The average ( standard deviation) percentage of
EBER-1-positive cells among PBMC was 25.0  11.4%. In the
isolated cell subpopulations of four patients, the dominant popu-
lation of EBER-1-positive cells was CD56+ NK cells
(61.8  14.1%). Very few T and B cells were positive for
EBER-1 in these patients. In spite of the low purity of B cells in
P5, the percentage of EBER-1-positive cells was 1.7%.
Increased subpopulation of activated NK cells. Consistent with
the findings of a previous report,(19) the number of CD56+ NK
cells was increased in all patients (Table 1) but not for those
with simple mosquito allergy (11.1  2.7%). As shown in Fig-
ure 2, the majority of these NK cells expressed HLA-DR
(92.6  4.2%), whereas a small number of NK cells in
controls and simple mosquito allergy patients expressed
HLA-DR (4.0  2.5%, 5.7  2.6%, respectively). The NK
lymphocytosis likely caused a relative decrease in the percent-
age of T cells. Although some T cells expressed HLA-DR
(23.8  10.6%), the CD4 ⁄8 ratios were normal in patients
with HMB. Our data showed that NK cells had significantly
more HLA-DR expression than T cells in the group with HMB
(P < 0.001).
Basophil activation test experiments. As shown in Fig-
ure 3(a), basophil activation occurred with exposure to the
extracts of epidemic mosquitoes in all samples from patients
with HMB, but no activation occurred in the absence of stimu-
lation. Basophils from normal controls were not activated by
mosquito antigens. When we examined in detail basophil acti-
vation on exposure to the respective antigens in samples from
patients with HMB, we detected basophil activation on expo-
sure to the extract of Ae. Albopictus, except in P4. Basophils
from P2, P3 and P4 were activated by the extract of C. p. pal-
lens. Both the extracts activated basophils in P2 and P3.
(a) (b)
Fig. 1. Cellular target of Epstein–Barr virus (EBV)
infection. (a) EBV-encoded small RNA-1 (EBER-1)
in situ hybridization of the lymphocyte
subpopulations in a representative patient with
hypersensitivity to mosquito bites. (b) The
percentages of EBER-1-positive cells in peripheral
blood mononuclear cells (PBMC) and the
lymphocyte subpopulations of patients with
hypersensitivity to mosquito bites are shown.
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When we compared the extent of CD63 and CD203c expres-
sion between the HMB group and the healthy control group,
the HMB group showed a significantly higher percentage of
CD63+ basophils that were stimulated by the extracts of
C. p. pallens or Ae. Albopictus (P < 0.05 and P < 0.001,
respectively) (Fig. 3b). Furthermore, both C. p. pallens and
Ae. Albopictus significantly upregulated CD203c expression in
the HMB group more than the control group (P < 0.05 and
P < 0.001, respectively) (Fig. 3c). In the HMB group, there
were significantly more basophils that upregulated CD63 and
CD203c expression after exposure to Ae. Albopictus compared
with C. p. pallens (P < 0.05 and P < 0.05, respectively)
(Fig. 3b,c). Similar to HMB, basophil activation by mosquito
extracts was detected in all samples from simple mosquito
allergy patients.
Discussion
We demonstrated basophil activation by mosquito antigens in
HMB. In particular, the extract of Ae. albopictus was able to
activate basophils in all available patient samples. Ae. albopic-
tus has been known to have a larger variety and amount of
allergens in the saliva compared with other species of mosqui-
toes.(20) Furthermore, Ae. albopictus is the most common spe-
cies associated with systemic allergic reactions to mosquito
bites.(21) In fact, the antigen of Ae. albopictus tended to induce
more basophil activation than C. p. pallens in our patients with
HMB. However, it remains unclear whether the antigen of
Ae. albopictus causes more intense clinical symptoms in
patients with HMB. In contrast, the extract of C. p. pallens
activated basophils from three patients with HMB, two of
whom showed basophil activation after exposure to either
extract. These different profiles of response to the mosquito
antigens may simply reflect the frequency of exposure to bites
of each species. Because the saliva of Ae. Albopictus contains
allergens that are common among different species, it is possi-
ble that basophil activation by C. p. pallens is the consequence
of the cross-reactivity of such allergens.(21)
Studies of T cells from patients with HMB show that mos-
quito antigens activate and induce proliferation of CD4+ T
cells and that these mosquito antigen-specific T cells induce
EBV reactivation in NK cells.(5,8) It is well known that signifi-
cant numbers of EBV-infected NK cells and reactive T cells
infiltrate into the bite sites in HMB.(7) Therefore, mosquito
antigen-specific CD4+ T and EBV-infected NK cells have been
considered to be responsible for intense skin lesions as well as
systemic symptoms in HMB. In the present study, we demon-
strated the presence of mosquito-specific IgE and basophil acti-
vation by mosquito antigens in vitro. The discrepancy
regarding mosquito-specific IgE between the BAT data and the
commercial fluorenzymeimmunoassay may be due to the dif-
ferent sensitivity of each method used for assessing mosquito-
specific IgE. It seems reasonable that mosquito antigens can
bind to mosquito-specific IgE attached to the high-affinity IgE
receptor of basophils and ⁄or mast cells at the bite sites, result-
ing in activation of such cells in HMB. In two patients whose
basophils were evaluated after successful hematopoietic stem
cell transplantation, basophil activation by mosquito antigens
was no longer detected in vitro (data not shown). Indeed, these
post-stem cell transplantation patients have had no symptoms
after mosquito bites.
Immediate allergic skin reactions via IgE-dependent mecha-
nisms soon after mosquito bites are also seen in simple mos-
quito allergy.(22) In fact, we demonstrated basophil activation
by mosquito antigens in all samples from simple mosquito
allergy patients. Subsequent bite-induced indurations in simple
mosquito allergy correlate with T-cell proliferation responses
to mosquito antigens. However, unlike simple mosquito
allergy, patients with HMB exhibit severe skin reactions and
systemic symptoms that might be the result of activation of
mosquito-specific CD4+ T cells and EBV-infected NK cells.
Basophils and ⁄or mast cells activated by the mosquito antigens
may produce humoral factors such as cytokines that potentially
activate CD4+ T cells and NK cells at the reaction sites. In
fact, activated basophils have been reported to produce various
cytokines, including IL-4, IL-9 and IL-13.(23,24) IL-4 is known
to induce proliferation of T cells, differentiation of na€ıve
CD4+ T cells into Th2 cells and a class switch to IgE in B
cells.(25–27) IL-13 can also promote a class switch to IgE in B
cells in vitro.(28) IL-9 has been showed to increases the num-
ber of EBV-infected NK cell lines of nasal NK ⁄T lymphoma
in vitro.(29) An analysis of serum cytokines from patients with
HMB showed high levels of IL-13, which might explain the
high serum IgE levels.(30) Further analysis of these cytokines
in serum or local skin lesions is needed to reveal the inflam-
matory processes in HMB. Taken together, these findings sug-
gest that antigen-induced activation of basophils and ⁄or mast
cells that bind to mosquito-specific IgE could be the initial
event and an additional mechanism leading to severe local skin
reactions and systemic symptoms in HMB.
Our immunological analysis clearly demonstrated prominent
EBV infection in NK cells, the proliferation of NK cells and
HLA-DR expression on almost all NK cells in HMB. Normal
NK cells do not usually express HLA-DR.(31,32) Consistent
with our previous study,(9) the percentage of activated NK
cells expressing HLA-DR was much higher than that of EBV-
infected NK cells in all patients with HMB. The reason why
the majority of non-infected NK cells expressed HLA-DR is
unclear. In contrast to NK cells, the minority of T cells
expressed HLA-DR in our patients. These findings differ from
those of IM, in which many T cells express HLA-DR.(33) The
difference in HLA-DR expression on T cells between HMB
and IM may be due to the types of antigens of EBV-infected
cells. EBV-infected B cells in IM express all EBV latent
Fig. 2. Expression of HLA-DR on T and natural killer (NK) cells. The
percentages of HLA-DR+ cells among CD3+ T and CD56+ NK cells in the
peripheral blood of healthy controls (n = 12), simple mosquito allergy
patients (n = 4) and patients with hypersensitivity to mosquito bites
are shown. Error bars indicate standard deviation.
© 2015 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd
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proteins, whereas EBV-infected T ⁄NK cells in CAEBV do not
express EBNA-3 family proteins that are dominant in cytotoxic
T lymphocytes (CTL) responses.(34,35) The absence of these
antigens is thought to impair CTL recognition of infected cells
in CAEBV. Thus, a low percentage of activated T cells in
HMB may be associated with markedly reduced CTL activ-
ity.(36)
From the clinical perspective, our results suggest an auxil-
iary method for the diagnosis of HMB. Although the proposed
guidelines have been shown to be helpful for the diagnosis of
HMB, the analysis of EBV viral load, clonality and cellular
target of EBV is only available in specialized laboratories. We
demonstrated that the existence of mosquito antigen-specific
IgE by BAT and selective activation and expansion of NK
cells, both of which reflect the pathogenesis of HMB, were
important features in HMB. These findings may help in the
diagnosis of HMB, although each isolated finding might not be
specific. Mosquito antigen-specific IgE has already been
(a)
(b) (c)
Fig. 3. Results of basophil activation tests. (a) Expression of CD63 and CD203c on basophils stimulated in vitro by the antigens of Culex pipiens
pallens (C. p.) or Aedes albopictus (Ae.) from representative individuals of normal control or simple mosquito allergy and patients with hypersen-
sitivity to mosquito bites (HMB). The percentage of cells gated in each region is shown. (b) The percentages of CD63+ cells within the population
of basophils stimulated by the antigens of Culex pipiens pallens or Aedes albopictus in the healthy control group (n = 12), simple mosquito
allergy (n = 5) and HMB group (n = 5 or 4, respectively). (c) The difference in mean fluorescence intensity (DMFI) of CD203c on basophils. DMFI
of CD203c was calculated by subtracting the MFI of unstimulated cells from those of stimulated cells. Error bars indicate standard deviation of
mean. *P < 0.05; **P < 0.001 based on Student’s t-test. NA, not applicable; ns, not significant.
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reported in patients with simple mosquito allergy.(22) Similarly,
an increased subpopulation of HLA-DR+ NK cells has been
found in patients with infections caused by herpes simplex
virus, dengue virus and Mycobacterium tuberculosis, as well
as aggressive NK cell leukemia.(37–40) However, concurrent
assessment of basophil activation by mosquito extracts and NK
cells might provide clues that lead to the diagnosis of HMB.
Further studies on whether this auxiliary method is useful as a
screening test of HMB are needed.
Limitations of the present study include the small sample
size, the ethnically homogeneous sample, and the absence of
patients with other forms of EBV infection. It has been
reported that the symptoms of HMB also occur in patients with
T-cell type CAEBV or NK cell leukemia ⁄ lymphoma.(3,41) Fur-
ther evaluation of patients with various types of EBV infection
or patients with a different ethnic background is necessary. It
is also necessary to assess whether mosquito-specific IgE is
present in cases of EBV-associated T ⁄NK-cell lymphoprolifer-
ative diseases without HMB. In addition, we used whole body
extracts that were easy to prepare. However, this might not be
ideal because they contained many extraneous proteins that
were not present in mosquito saliva.(42) Although saliva from
living mosquitoes would be the best source of antigens, it is
technically difficult and time-consuming to obtain large
enough quantities of saliva.(21,42) It has been reported that
recombinant Aedes aegypti salivary antigens can be used in
the in vitro and in vivo diagnosis of mosquito allergy and are
more sensitive than whole body extracts.(43,44) These antigens
may increase the sensitivity and specificity of BAT.
In conclusion, our study demonstrated the activation of cir-
culating basophils by mosquito extracts in vitro and suggested
the involvement of activated basophils and ⁄ or mast cells carry-
ing mosquito-specific IgE on their cell membranes in the initi-
ation and development of severe skin reactions to mosquito
bites in HMB.
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(a)
(b) (c)
Basophil activation tests with the extracts of epidemic mosquitoes showed positive responses in all samples from patients with HMB. These
results suggest that mosquito antigen-specific IgE and activated basophils and ⁄ or mast cells may be involved in initiation and development of
severe skin reactions to mosquito bites through IgE-mediated mechanisms in HMB.
